Aberrant CD19 Expression on CD8 ‐Positive T‐Cell Lymphoma
International Journal of Laboratory Hematology · 2026-08 · 48 (4) · 710-712
DOI: 10.1111/ijlh.70098 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 25.03.2026. Verfasst von Brian Vadasz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pathology, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Zitieren
APA
Vadasz, B., Liu, Y., & Chen, Q. (2026). Aberrant CD19 Expression on CD8 ‐Positive T‐Cell Lymphoma. International Journal of Laboratory Hematology, 48(4), 710-712. https://doi.org/10.1111/ijlh.70098
Vancouver
Vadasz B, Liu Y, Chen Q. Aberrant CD19 Expression on CD8 ‐Positive T‐Cell Lymphoma. International Journal of Laboratory Hematology. 2026;48(4):710-712. doi:10.1111/ijlh.70098
BibTeX
@article{Vadasz2026,
author = {Vadasz, Brian and Liu, Yijie and Chen, Qing},
title = {Aberrant CD19 Expression on CD8 ‐Positive T‐Cell Lymphoma},
journal = {International Journal of Laboratory Hematology},
year = {2026},
volume = {48},
number = {4},
pages = {710--712},
doi = {10.1111/ijlh.70098}
}
EUVIMED